The "no reflow" phenomenon following acute myocardial infarction: Mechanisms and treatment options

    Research output: Contribution to journalArticle

    34 Citations (Scopus)

    Abstract

    If 'no reflow' is observed within 45. min of reperfusion using balloon angioplasty or stent, it is probably related to microthromboemboli, which may also contribute to the extension of the 'no reflow' zone by converting 'low reflow' areas into necrotic ones even when reperfusion is achieved more than 45. min after the onset of coronary occlusion. Since 'no reflow' is noted when 45. min of coronary occlusion has elapsed even in the absence of a thrombus, 'no reflow' late after reperfusion is predominantly due to tissue necrosis and unlikely to be resolved unless methods to reduce infarct size are used.Attempts at reducing the intracoronary thrombus burden during a coronary procedure for acute myocardial infarction (AMI) have been shown to reduce 'no reflow' and improve clinical outcome, as has the use of potent antithrombotic agents. Drugs that can reduce infarct size, when given intracoronary or intravenous in conjunction with a coronary intervention during AMI can also reduce 'no reflow' and improve outcomes in patients with AMI.The prognostic importance of 'no reflow' post-AMI is related to its close correspondence with infarct size. Although several imaging and non-imaging methods have been used to assess 'no reflow' or 'low reflow' myocardial contrast echocardiography remains the ideal method for its assessment both in and outside the cardiac catheterization laboratory.

    Original languageEnglish (US)
    Pages (from-to)77-85
    Number of pages9
    JournalJournal of Cardiology
    Volume64
    Issue number2
    DOIs
    StatePublished - 2014

    Fingerprint

    No-Reflow Phenomenon
    Myocardial Infarction
    Reperfusion
    Coronary Occlusion
    Thrombosis
    Balloon Angioplasty
    Fibrinolytic Agents
    Therapeutics
    Cardiac Catheterization
    Stents
    Echocardiography
    Necrosis
    Pharmaceutical Preparations

    Keywords

    • Myocardial contrast echocardiography
    • Myocardial infarction
    • No reflow

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine
    • Medicine(all)

    Cite this

    The "no reflow" phenomenon following acute myocardial infarction : Mechanisms and treatment options. / Kaul, Sanjiv.

    In: Journal of Cardiology, Vol. 64, No. 2, 2014, p. 77-85.

    Research output: Contribution to journalArticle

    @article{a8fdb6198024490f9adc429692f8dad3,
    title = "The {"}no reflow{"} phenomenon following acute myocardial infarction: Mechanisms and treatment options",
    abstract = "If 'no reflow' is observed within 45. min of reperfusion using balloon angioplasty or stent, it is probably related to microthromboemboli, which may also contribute to the extension of the 'no reflow' zone by converting 'low reflow' areas into necrotic ones even when reperfusion is achieved more than 45. min after the onset of coronary occlusion. Since 'no reflow' is noted when 45. min of coronary occlusion has elapsed even in the absence of a thrombus, 'no reflow' late after reperfusion is predominantly due to tissue necrosis and unlikely to be resolved unless methods to reduce infarct size are used.Attempts at reducing the intracoronary thrombus burden during a coronary procedure for acute myocardial infarction (AMI) have been shown to reduce 'no reflow' and improve clinical outcome, as has the use of potent antithrombotic agents. Drugs that can reduce infarct size, when given intracoronary or intravenous in conjunction with a coronary intervention during AMI can also reduce 'no reflow' and improve outcomes in patients with AMI.The prognostic importance of 'no reflow' post-AMI is related to its close correspondence with infarct size. Although several imaging and non-imaging methods have been used to assess 'no reflow' or 'low reflow' myocardial contrast echocardiography remains the ideal method for its assessment both in and outside the cardiac catheterization laboratory.",
    keywords = "Myocardial contrast echocardiography, Myocardial infarction, No reflow",
    author = "Sanjiv Kaul",
    year = "2014",
    doi = "10.1016/j.jjcc.2014.03.008",
    language = "English (US)",
    volume = "64",
    pages = "77--85",
    journal = "Journal of cardiography. Supplement",
    issn = "0914-5087",
    publisher = "Japanese College of Cardiology (Nippon-Sinzobyo-Gakkai)",
    number = "2",

    }

    TY - JOUR

    T1 - The "no reflow" phenomenon following acute myocardial infarction

    T2 - Mechanisms and treatment options

    AU - Kaul, Sanjiv

    PY - 2014

    Y1 - 2014

    N2 - If 'no reflow' is observed within 45. min of reperfusion using balloon angioplasty or stent, it is probably related to microthromboemboli, which may also contribute to the extension of the 'no reflow' zone by converting 'low reflow' areas into necrotic ones even when reperfusion is achieved more than 45. min after the onset of coronary occlusion. Since 'no reflow' is noted when 45. min of coronary occlusion has elapsed even in the absence of a thrombus, 'no reflow' late after reperfusion is predominantly due to tissue necrosis and unlikely to be resolved unless methods to reduce infarct size are used.Attempts at reducing the intracoronary thrombus burden during a coronary procedure for acute myocardial infarction (AMI) have been shown to reduce 'no reflow' and improve clinical outcome, as has the use of potent antithrombotic agents. Drugs that can reduce infarct size, when given intracoronary or intravenous in conjunction with a coronary intervention during AMI can also reduce 'no reflow' and improve outcomes in patients with AMI.The prognostic importance of 'no reflow' post-AMI is related to its close correspondence with infarct size. Although several imaging and non-imaging methods have been used to assess 'no reflow' or 'low reflow' myocardial contrast echocardiography remains the ideal method for its assessment both in and outside the cardiac catheterization laboratory.

    AB - If 'no reflow' is observed within 45. min of reperfusion using balloon angioplasty or stent, it is probably related to microthromboemboli, which may also contribute to the extension of the 'no reflow' zone by converting 'low reflow' areas into necrotic ones even when reperfusion is achieved more than 45. min after the onset of coronary occlusion. Since 'no reflow' is noted when 45. min of coronary occlusion has elapsed even in the absence of a thrombus, 'no reflow' late after reperfusion is predominantly due to tissue necrosis and unlikely to be resolved unless methods to reduce infarct size are used.Attempts at reducing the intracoronary thrombus burden during a coronary procedure for acute myocardial infarction (AMI) have been shown to reduce 'no reflow' and improve clinical outcome, as has the use of potent antithrombotic agents. Drugs that can reduce infarct size, when given intracoronary or intravenous in conjunction with a coronary intervention during AMI can also reduce 'no reflow' and improve outcomes in patients with AMI.The prognostic importance of 'no reflow' post-AMI is related to its close correspondence with infarct size. Although several imaging and non-imaging methods have been used to assess 'no reflow' or 'low reflow' myocardial contrast echocardiography remains the ideal method for its assessment both in and outside the cardiac catheterization laboratory.

    KW - Myocardial contrast echocardiography

    KW - Myocardial infarction

    KW - No reflow

    UR - http://www.scopus.com/inward/record.url?scp=84905578499&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84905578499&partnerID=8YFLogxK

    U2 - 10.1016/j.jjcc.2014.03.008

    DO - 10.1016/j.jjcc.2014.03.008

    M3 - Article

    C2 - 24799155

    AN - SCOPUS:84905578499

    VL - 64

    SP - 77

    EP - 85

    JO - Journal of cardiography. Supplement

    JF - Journal of cardiography. Supplement

    SN - 0914-5087

    IS - 2

    ER -